Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis (Q39191957)

9 September 2017

title

Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis (English)

1 reference

9 September 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Silvia Stacchiotti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Michele Guida

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Giovanni Grignani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Akmal Safwat

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Alessandro Gronchi

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

A Kollár

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

H Gelderblom

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

N Steeghs

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

D Katz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

F Duffaud

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

S Sleijfer

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

W T van der Graaf

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

N Touati

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

S Litière

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

S Marreaud

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

B Kasper

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

14 November 2016

1 reference

9 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

88-92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

Irradiation-induced angiosarcoma and anti-angiogenic therapy: a therapeutic hope?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

Pazopanib: Clinical development of a potent anti-angiogenic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

Pazopanib: a promising new agent in the treatment of soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

Successful treatment of pulmonary artery sarcoma by a two-drug combination chemotherapy consisting of ifosfamide and epirubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1234068

10.1080/0284186X.2016.1234068

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27838944%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference